Viewing StudyNCT06302374



Ignite Creation Date: 2024-05-06 @ 8:13 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06302374
Status: COMPLETED
Last Update Posted: 2024-03-08
First Post: 2024-02-28

Brief Title: Safety Tolerability Pharmacokinetics Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adults
Sponsor: Genrix Shanghai Biopharmaceutical Co Ltd
Organization: Genrix Shanghai Biopharmaceutical Co Ltd

Organization Data

Organization: Genrix Shanghai Biopharmaceutical Co Ltd
Class: INDUSTRY
Study ID: GR2001-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Genrix Shanghai Biopharmaceutical Co Ltd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators